Imitrex vs. Ajovy

See how Imitrex and Ajovy compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Imitrex treats a migraine attack after it starts, while Ajovy is taken on a regular schedule to prevent migraines before they begin.

  • Imitrex works within hours as a tablet, injection, or nasal spray, while Ajovy is injected once a month or once every three months.

  • Imitrex carries cardiovascular warnings that Ajovy does not, while Ajovy commonly causes injection site reactions and rarely serious allergic reactions.

Imitrex vs. Ajovy Drug Summary

Imitrex

Imitrex (sumatriptan) is a triptan that narrows blood vessels and blocks pain signals during a migraine attack. It is taken as a tablet, injection, or nasal spray at the first sign of a migraine, with a repeat dose allowed after two hours if needed. It treats migraine and cluster headache attacks but does not prevent future migraines.

Ajovy

Ajovy (fremanezumab-vfrm) is a CGRP monoclonal antibody used to prevent migraines before they start rather than treat an attack in progress. It is given as a subcutaneous injection either once a month or as a larger dose once every three months. It is approved for adults and for adolescents 6 to 17 who weigh at least 45 kg.

Imitrex vs. Ajovy Side Effects

Imitrex

Most common
warm/cold sensation (up to 3%)

Ajovy

Most common
injection site reactions (38% to 45%)

Imitrex vs. Ajovy Dosage

Imitrex

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 25 mg, 50 mg, or 100 mg At the start
Maximum dose Repeat dose, max 200mg/day If needed
Dose changes 1 increase As tolerated

Ajovy

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 225 mg once monthly At the start
Maximum dose 675 mg every 3 months If needed
Dose changes 1 increase As tolerated

Imitrex vs. Ajovy Indications

Imitrex

Imitrex is FDA-approved for the acute treatment of migraine attacks with or without aura in adults, and the injectable form also treats cluster headache. It is taken only when a migraine starts, not on a daily schedule. It is not approved to prevent migraines or for use in children.

  • Acute migraine treatment in adults

  • Cluster headache treatment (injection only)

  • Taken at onset of migraine symptoms

  • Not approved for migraine prevention

  • Not approved for patients under 18

Ajovy

Ajovy is FDA-approved for the preventive treatment of migraine in adults, given as a regular injection to lower how often migraines occur. It is also approved for adolescents ages 6 to 17 who weigh at least 45 kg. It is not intended to treat a migraine that has already started.

  • Preventive migraine treatment in adults

  • Preventive treatment for ages 6-17 (45+ kg)

  • Given monthly or every 3 months

  • Not approved for acute migraine attacks

  • No pediatric use under 6 years or 45 kg

Imitrex vs. Ajovy Pros and Cons

Imitrex

Imitrex has been used since 1992 and offers multiple delivery options for fast relief once a migraine begins. It is widely available as a generic and typically works within a couple of hours for most patients. Its cardiovascular warnings mean it is not a safe option for everyone.

Pros

  • Multiple forms: tablet, injection, or nasal spray

  • Works within hours of an attack starting

  • Decades of clinical use and prescribing history

  • Only taken when needed, not on a fixed schedule

Cons

  • Not effective for migraine prevention

  • Contraindicated with heart disease or stroke risk

  • Cannot combine with other triptans within 24 hours

  • Frequent use risks medication overuse headache

Ajovy

Ajovy targets the CGRP pathway to reduce migraine frequency over time rather than treat individual attacks. Its infrequent dosing schedule appeals to patients who want to avoid daily pills, and its safety profile has been well studied in trials. As a newer biologic, it still requires ongoing injections and carries its own risks.

Pros

  • Reduces migraine frequency instead of treating attacks

  • Only 1 injection a month or 3 every 3 months

  • Approved for adolescents 6 to 17 years old

  • Long-lasting effect from a 30-day half-life

Cons

  • Does not relieve a migraine once it starts

  • Injection site reactions are common

  • Risk of rare hypersensitivity reactions

  • No generic version currently available

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.